Altered NK Cell Development and Enhanced NK Cell-Mediated Resistance to Mouse Cytomegalovirus in NKG2D-Deficient Mice

Immunity

Volumn 31, Issue 2, 2009, Pages 270-282

  Zafirova, Biljana ^a   Mandarić, Sanja ^a   Antulov, Ronald ^a   Krmpotić, Astrid ^a   Jonsson, Helena ^b   Yokoyama, Wayne M ^b   Jonjić, Stipan ^a   Polić, Bojan ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CELLIMMUNO; MOLIMMUNO

Indexed keywords

LIGAND; NATURAL KILLER CELL RECEPTOR NKG2D;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DIVISION; CELL FUNCTION; CELL MATURATION; CELL SIZE; CELL STRESS; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GENE LOCUS; INFECTION RESISTANCE; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEM CELL;

ANIMALS; HERPESVIRIDAE INFECTIONS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUROMEGALOVIRUS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; SPLEEN;

EID: 68649112523     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2009.06.017     Document Type: Article

References (55)

1. Arapovic J., Lenac T., Antulov R., Polic B., Ruzsics Z., Carayannopoulos L.N., Koszinowski U.H., Krmpotic A., and Jonjic S. Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus. J. Vir. (2009) 10.1128/JVI.02549-08 Published online June 3, 2009
2. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., and Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296 (2002) 1323-1326
3. Bacon L., Eagle R.A., Meyer M., Easom N., Young N.T., and Trowsdale J. Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D. J. Immunol. 173 (2004) 1078-1084
4. Bakker A.B., Hoek R.M., Cerwenka A., Blom B., Lucian L., McNeil T., Murray R., Phillips L.H., Sedgwick J.D., and Lanier L.L. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13 (2000) 345-353
5. Bartkova J., Horejsi Z., Koed K., Kramer A., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434 (2005) 864-870
6. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., and Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285 (1999) 727-729
7. Bonnema J.D., Karnitz L.M., Schoon R.A., Abraham R.T., and Leibson P.J. Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity. J. Exp. Med. 180 (1994) 1427-1435
8. Brown M.G., Dokun A.O., Heusel J.W., Smith H.R., Beckman D.L., Blattenberger E.A., Dubbelde C.E., Stone L.R., Scalzo A.A., and Yokoyama W.M. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292 (2001) 934-937
9. Brune W., Hengel H., and Koszinowski U.H. A mouse model for cytomegalovirus infection. In: Coligan J.E., et al. (Ed). Current Protocols in Immunology (2001), John Wiley &Sons, Hoboken, NJ 1-13
10. Bubic I., Wagner M., Krmpotic A., Saulig T., Kim S., Yokoyama W.M., Jonjic S., and Koszinowski U.H. Gain of virulence caused by loss of a gene in murine cytomegalovirus. J. Virol. 78 (2004) 7536-7544
11. Burkett P.R., Koka R., Chien M., Chai S., Boone D.L., and Ma A. Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis. J. Exp. Med. 200 (2004) 825-834
12. Cerwenka A., Baron J.L., and Lanier L.L. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA 98 (2001) 11521-11526
13. Cosman D., Mullberg J., Sutherland C.L., Chin W., Armitage R., Fanslow W., Kubin M., and Chalupny N.J. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14 (2001) 123-133
14. Coudert J.D., Scarpellino L., Gros F., Vivier E., and Held W. Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways. Blood 111 (2008) 3571-3578
15. Daniels K.A., Devora G., Lai W.C., O'Donnell C.L., Bennett M., and Welsh R.M. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med. 194 (2001) 29-44
16. Diefenbach A., Jensen E.R., Jamieson A.M., and Raulet D.H. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413 (2001) 165-171
17. Diefenbach A., Tomasello E., Lucas M., Jamieson A.M., Hsia J.K., Vivier E., and Raulet D.H. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat. Immunol. 3 (2002) 1142-1149
18. Di Santo J.P. Natural killer cell developmental pathways: A question of balance. Annu. Rev. Immunol. 24 (2006) 257-286
19. French A.R., Sjolin H., Kim S., Koka R., Yang L., Young D.A., Cerboni C., Tomasello E., Ma A., Vivier E., et al. DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections. J. Immunol. 177 (2006) 4981-4990
20. Gasser S., Orsulic S., Brown E.J., and Raulet D.H. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436 (2005) 1186-1190
21. Gilfillan S., Ho E.L., Cella M., Yokoyama W.M., and Colonna M. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat. Immunol. 3 (2002) 1150-1155
22. Gorgoulis V.G., Vassiliou L.V., Karakaidos P., Zacharatos P., Kotsinas A., Liloglou T., Venere M., Ditullio Jr. R.A., Kastrinakis N.G., Levy B., et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434 (2005) 907-913
23. Groh V., Rhinehart R., Randolph-Habecker J., Topp M.S., Riddell S.R., and Spies T. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2 (2001) 255-260
24. Guerra N., Tan Y.X., Joncker N.T., Choy A., Gallardo F., Xiong N., Knoblaugh S., Cado D., Greenberg N.M., and Raulet D.H. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 28 (2008) 571-580
25. Hayakawa Y., and Smyth M.J. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 176 (2006) 1517-1524
26. Ho E.L., Carayannopoulos L.N., Poursine-Laurent J., Kinder J., Plougastel B., Smith H.R., and Yokoyama W.M. Costimulation of multiple NK cell activation receptors by NKG2D. J. Immunol. 169 (2002) 3667-3675
27. Horng T., Bezbradica J.S., and Medzhitov R. NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway. Nat. Immunol. 8 (2007) 1345-1352
28. Huntington N.D., Puthalakath H., Gunn P., Naik E., Michalak E.M., Smyth M.J., Tabarias H., Degli-Esposti M.A., Dewson G., Willis S.N., et al. Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1. Nat. Immunol. 8 (2007) 856-863
29. Huntington N.D., Vosshenrich C.A., and Di Santo J.P. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat. Rev. Immunol. 7 (2007) 703-714
30. Idris A.H., Smith H.R., Mason L.H., Ortaldo J.R., Scalzo A.A., and Yokoyama W.M. The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing. Proc. Natl. Acad. Sci. USA 96 (1999) 6330-6335
31. Jiang K., Zhong B., Gilvary D.L., Corliss B.C., Hong-Geller E., Wei S., and Djeu J.Y. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat. Immunol. 1 (2000) 419-425
32. Jiang K., Zhong B., Gilvary D.L., Corliss B.C., Vivier E., Hong-Geller E., Wei S., and Djeu J.Y. Syk regulation of phosphoinositide 3-kinase-dependent NK cell function. J. Immunol. 168 (2002) 3155-3164
33. Jiang K., Zhong B., Ritchey C., Gilvary D.L., Hong-Geller E., Wei S., and Djeu J.Y. Regulation of Akt-dependent cell survival by Syk and Rac. Blood 101 (2003) 236-244
34. Jonjic S., Babic M., Polic B., and Krmpotic A. Immune evasion of natural killer cells by viruses. Curr. Opin. Immunol. 20 (2008) 30-38
35. Kuhn R., and Torres R.M. Cre/loxP recombination system and gene targeting. Methods Mol. Biol. 180 (2002) 175-204
36. Lanier L.L., and Bakker A.B. The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function. Immunol. Today 21 (2000) 611-614
37. Lee S.H., Girard S., Macina D., Busa M., Zafer A., Belouchi A., Gros P., and Vidal S.M. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. 28 (2001) 42-45
38. Lucas M., Schachterle W., Oberle K., Aichele P., and Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26 (2007) 503-517
39. MacFarlane A.W., Yamazaki T., Fang M., Sigal L.J., Kurosaki T., and Campbell K.S. Enhanced NK-cell development and function in BCAP-deficient mice. Blood 112 (2008) 131-140
40. Nguyen K.B., Salazar-Mather T.P., Dalod M.Y., Van Deusen J.B., Wei X.Q., Liew F.Y., Caligiuri M.A., Durbin J.E., and Biron C.A. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169 (2002) 4279-4287
41. Ogasawara K., Hamerman J.A., Ehrlich L.R., Bour-Jordan H., Santamaria P., Bluestone J.A., and Lanier L.L. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 20 (2004) 757-767
42. Ogasawara K., Benjamin J., Takaki R., Phillips J.H., and Lanier L.L. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts. Nat. Immunol. 6 (2005) 938-945
43. Okada T., Maeda A., Iwamatsu A., Gotoh K., and Kurosaki T. BCAP: The tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity 13 (2000) 817-827
44. Oppenheim D.E., Roberts S.J., Clarke S.L., Filler R., Lewis J.M., Tigelaar R.E., Girardi M., and Hayday A.C. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat. Immunol. 6 (2005) 928-937
45. Orange J.S., and Biron C.A. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156 (1996) 4746-4756
46. Raulet D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3 (2003) 781-790
47. Robbins S.H., Tessmer M.S., Mikayama T., and Brossay L. Expansion and contraction of the NK cell compartment in response to murine cytomegalovirus infection. J. Immunol. 173 (2004) 259-266
48. Saez-Borderias A., Guma M., Angulo A., Bellosillo B., Pende D., and Lopez-Botet M. Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus. Eur. J. Immunol. 36 (2006) 3198-3206
49. Sjolin H., Tomasello E., Mousavi-Jazi M., Bartolazzi A., Karre K., Vivier E., and Cerboni C. Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J. Exp. Med. 195 (2002) 825-834
50. Smith H.R., Heusel J.W., Mehta I.K., Kim S., Dorner B.G., Naidenko O.V., Iizuka K., Furukawa H., Beckman D.L., Pingel J.T., et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99 (2002) 8826-8831
51. Tomasello E., Desmoulins P.O., Chemin K., Guia S., Cremer H., Ortaldo J., Love P., Kaiserlian D., and Vivier E. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. Immunity 13 (2000) 355-364
52. Wiemann K., Mittrucker H.W., Feger U., Welte S.A., Yokoyama W.M., Spies T., Rammensee H.G., and Steinle A. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo. J. Immunol. 175 (2005) 720-729
53. Wu J., Song Y., Bakker A.B., Bauer S., Spies T., Lanier L.L., and Phillips J.H. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285 (1999) 730-732
54. Wu J., Cherwinski H., Spies T., Phillips J.H., and Lanier L.L. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J. Exp. Med. 192 (2000) 1059-1068
55. Zompi S., Hamerman J.A., Ogasawara K., Schweighoffer E., Tybulewicz V.L., Di Santo J.P., Lanier L.L., and Colucci F. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nat. Immunol. 4 (2003) 565-572